All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 10 out of 78 Insights
In this Harvard Macy Institute blog post, learn how implementation science, faculty development, and dedicated expertise can help turn promising curriculum reforms into lasting changes in educational practice.
HealthSpark, Episode 31: Jeff Levin-Scherz, Assistant Professor in the Department of Health Policy and Management at Harvard T.H. Chan School of Public Health and Harvard Medical School, explores the promise of GLP-1 medications and the challenges that determine who can benefit from them.
HealthSpark, Episode 30: David Bernstein, orthopedic surgeon at Massachusetts General Hospital and Affiliate Scholar at the Hopkins Business of Health Initiative, explores how routinely tracking patient-reported outcomes and rewarding care teams for improving them could help health systems control costs while making people healthier.
In this Harvard Macy Institute blog post, how medical education can help students better understand patients’ perspectives through direct observation, narrative reflection, and time spent with patients and families is discussed.
While GLP-1–based therapies are expanding from diabetes treatment to broad multi-system care, their growing complexity is reshaping clinical collaboration, health system organization, and the ongoing challenge of making these transformative medications affordable and accessible.
In this Harvard Macy Institute blog post, an integrated approach to developing clinical leadership and teamwork skills across all levels of healthcare teams is discussed.
HealthSpark, Episode 25: Fatima Cody Stanford, an obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School, reflects on why obesity is one of modern medicine's most complex challenges and how coordinated action across care delivery, public health, and industry can reduce its impact on patients, health systems, and economies worldwide.
HealthSpark, Episode 24: Tisha Boatman, Executive Vice President of External Affairs at Siemens Healthineers, reflects on how changing funding dynamics, shifting attitudes toward collaboration, and a more ecosystem‑oriented mindset are redefining the role of the private sector in health systems worldwide.
From diagnosis and risk prediction to treatment selection and drug development, biomarkers quietly power the precision and progress of modern medicine.
From diagnosis and risk prediction to treatment selection and drug development, biomarkers quietly power the precision and progress of modern medicine.